Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: XB³-001

From page 18, June 29 presentation.....

XB³-001

IND submission (2021) and initiation of Phase 1b component of trial (2022)
Completion of dose escalation phase and EOPI meeting (2023)
Completion of Phase 2 expansion cohort (2023)

Share
New Message
Please login to post a reply